Press
Releases

Press Releases

June 3, 2022
Altimmune to Participate at Two Upcoming Investor Conferences
GAITHERSBURG, Md. , June 03, 2022 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate at the following investor conferences in June 2022 : Jefferies 2022 Global Healthcare
May 16, 2022
Altimmune to Present at Upcoming Investor Conferences
GAITHERSBURG, Md. , May 16, 2022 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate at the following investor conferences in May 2022 : H.C.
 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe